Assessment of a Novel Nutritive Solution (NUTRIMOV) and Sodium Diatrizoate (Gastrografin) Booster for Bowel Cleaning Prior to Colonoscopy | ||||
| The Medical Journal of Cairo University | ||||
| Volume 90, Issue 9, September 2022, Page 1435-1438 PDF (36.59 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjcu.2022.264598 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| AMERAH TALEB, M.D.; NORAN ROSHDY, M.Sc.; MOSTAFA IBRAHIM, M.D. | ||||
| The Department of Research, New Giza University, Giza*, Department of Gastroenterology, Hepatology & Endoscopy, ROEYA Endoscopy Center, Cairo** and Department of Gastroenterology & Hepatology, Theodor Bilharz Research Institute, Giza*** | ||||
| Abstract | ||||
| Abstract Background: Sensitivity of colonoscopy in detecting pre-cancerous lesions depends on quality bowel preparation that is often negatively affected by low tolerability of patients to the different preparation protocols. Aim of Study: To evaluate the efficacy and tolerability of a novel solution (NUTRIMOV) combining PEG and a carbo-hydrate-electrolyte solution for colonoscopy. Patients and Methods: Fifty patients undergoing colorectal cancer (CRC) screening via colonoscopy. Split-dose of 4 L of NUTRIMOV were administered over a span of three days leading up to the colonoscopy. Results: Fifty patients (26 males, mean age 55±8 years) were included in the final analysis. Excellent and good bowel preparation was achieved in 72% of patients. Patient's tolera-bility was reported as good in 43%, moderate in 42% and poor in 15%. Adverse effects were hunger (22%), fatigue (36%), abdominal pain (4%), bloating (24%), but no vomiting (0%). Conclusion: NUTRIMOV is well tolerated by patients with low rates of adverse effects and results in high rates of adequate cleansing level. | ||||
| Keywords | ||||
| Colonoscopy; Preparation; Polyethylene Glycols | ||||
|
Statistics Article View: 107 PDF Download: 65 |
||||
